top of page
Embryonic Stem Cells_edited.jpg

Developing novel tools for immunotherapy

About Cellmover

Cellmover is a pre-clinical stage immunotherapy company committed to optimizing the tools of the immune system, with a vision to broaden the application of immunotherapies for various cancers.


Immunotherapy includes strategies to enhance immune cell activation in patients to better target cancers, as well as cell-based therapies where patients receive genetically modified immune cells targeting cancer cells. Our main strategy is to increase the presence of active lymphocytes in the tumors by boosting the activity of  T-cells and NK-cells within the tumor microenvironment.

Uten navn(1).png
bottom of page